Biomerica (BMRA) said Thursday it received three international patents covering the technology and methods for treating gastroesophageal reflux disease, Crohn's disease, and ulcerative colitis using its inFoods technology.
The patents cover countries under the European Patent Organization, including the UK, Germany, France, Italy, and Spain, the company said.
Biomerica shares were up 4% in recent trading.
Price: 0.33, Change: +0.01, Percent Change: +4.06
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.